News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flynn James E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Terns Pharmaceuticals, Inc. |
| 10/04/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Evolus, Inc. |
| 08/14/2023 |
SC 13G/A
| Flynn James E reports a 7.4% stake in Singular Genomics Systems, Inc. |
| 06/09/2023 |
SC 13G/A
| Flynn James E reports a 4.9% stake in GeneDX Holdings Corp. |
| 05/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Rain Oncology Inc. |
| 05/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 39.2% stake in Nuvalent, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 5.7% stake in AdaptHealth Corp. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 9.1% stake in Singular Genomics Systems, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 1.8% stake in Peak Bio, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Turmeric Acquisition Corp. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 2.5% stake in Orchard Therapeutics plc |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Organogenesis Holdings Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 3.6% stake in Kura Oncology, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Inozyme Pharma, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 6.2% stake in Edgewise Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Aerie Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 5.1% stake in Abeona Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 3.5% stake in Deciphera Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 4.2% stake in Cogent Biosciences, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 5.8% stake in Vigil Neuroscience, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 5.1% stake in Merus N.V. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 5.5% stake in Mirum Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 8.1% stake in HilleVax, Inc. |
|
|
|